News

Relay Therapeutics to Join Notable Investor Conferences in September

Relay Therapeutics to Join Notable Investor Conferences in September

Relay Therapeutics Announces Participation in Upcoming Investor Conferences

Relay Therapeutics, Inc. (Nasdaq: RLAY), based in Cambridge, Massachusetts, is making significant strides in the development of cutting-edge therapies aimed at transforming the lives of individuals battling cancer and genetic diseases. The company recently shared that its management team will engage in two prominent fireside chats scheduled for September.

Details on Conferences

The first event is the 2025 Wells Fargo Healthcare Conference, set for September 4, 2025, at 2:15 PM ET. Following shortly after, Relay Therapeutics will also be part of the Morgan Stanley 23rd Annual Global Conference, occurring on September 10, 2025, at 11:30 AM ET. These fireside chats are poised to be informative moments where management will discuss the company’s intricate initiatives and breakthroughs in precision medicine.

Accessing the Webcasts

Both discussions will be available for live streaming on Relay Therapeutics’ official website, particularly in the News & Events section. For those unable to attend the live sessions, archived replays will be accessible for up to 30 days post-event, ensuring that interested parties remain informed about the latest developments.

About Relay Therapeutics

Relay Therapeutics is recognized for its pioneering work in small molecule precision medicine. The firm is committed to advancing potentially transformative therapies for patients grappling with cancer and genetic disorders. Central to Relay's research is the innovative Dynamo platform, which combines state-of-the-art computational and experimental methodologies to target previously unapproachable protein targets. This platform positions Relay strongly at the forefront of medical innovation.

Clinical Advancement of RLY-2608

Relay's flagship clinical asset, RLY-2608, stands out as the first pan-mutant selective PI3K? inhibitor currently in clinical development. This innovative treatment is presently undergoing a Phase 3 trial, known as ReDiscover-2, focusing on HR+/HER2- metastatic breast cancer. In addition to this, RLY-2608 is also being evaluated for a set of genetic disease conditions characterized by PI3K?-driven vascular malformations.

Research Pipeline and Future Prospects

Looking ahead, Relay Therapeutics is nurturing a robust pipeline that includes several late-stage research initiatives targeting NRAS-driven solid tumors and the rare Fabry disease. The company remains committed to pushing the boundaries of what's possible in precision medicine, making significant impacts on patient care and treatment outcomes.

Stay Updated with Relay Therapeutics

More detailed information about Relay Therapeutics and its innovative approaches to therapy can be found on the company’s official website. They also invite individuals to connect and follow their latest updates on LinkedIn, ensuring that community members stay informed about their ongoing research and developments.

Contact Information

For inquiries regarding corporate affairs or media relations, interested parties can reach out to Pete Rahmer at prahmer@relaytx.com, or for media-related concerns, connect with Dan Budwick at 1AB by calling 973-271-6085 or emailing dan@1abmedia.com.

Frequently Asked Questions

What is Relay Therapeutics known for?

Relay Therapeutics is known for its work in developing precision medicines, specifically targeting cancer and genetic diseases through innovative therapies.

When are the upcoming investor conferences?

The conferences are the Wells Fargo Healthcare Conference on September 4, 2025, and the Morgan Stanley Global Conference on September 10, 2025.

How can I access the conference webcasts?

The live webcasts can be accessed through Relay Therapeutics’ website, specifically in the News & Events section.

What is RLY-2608?

RLY-2608 is Relay's lead clinical asset, a selective PI3K? inhibitor currently being tested in trials for metastatic breast cancer.

How can I stay updated with Relay Therapeutics?

You can visit Relay’s official website and follow their LinkedIn page for the latest updates on their research and developments.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 184

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 451

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 314

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading
2027 Toy of the Year Finalists Energize Play Market

Updated Category News Views 272

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 183

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 262

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
FuelCell Faces Class Action Crunch as Deadline Looms

Updated Category News Views 192

FuelCell's Legal Storm: What to Know Now You ever get that feeling when your gut knows it all before you even finish reading the headline? Well, buckle up, because FuelCell Energy, Inc. (NASDAQ:FCEL) is staring down a potential class-action train wreck, and they ain't got much track left to skid on before the deadline hits hard on November 10th, 2026. The Crunchy Details...

Continue Reading
JOYEE N01 Kicks Off Global Launch with African Orders

Updated Category News Views 319

A New Chapter for JOYEE N01 There's a moment in every company's life when it either steps boldly into the future or stumbles back into obscurity. For FAW Bestune, October 28, 2026, was one of those defining moments. On this day, they launched global mass production of the JOYEE N01 in Yancheng, China. And boy, did they pull out all the stops—you don't see this kind of...

Continue Reading
7th World Media Summit Spotlights Media's Future in Beijing

Updated Category News Views 235

The Changing Landscape of Global Media An event of this magnitude doesn't just pop up every day like a stock ticker on Wall Street. This year's 7th World Media Summit in Beijing is where nearly 500 bigwigs from all corners of the media landscape are converging. It's not about trading stocks or hitting quarterly numbers—it's about shaping how stories get told in an era...

Continue Reading
NatGold Pulling NATG From MEXC Amid Security Concerns

Updated Category News Views 427

NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...

Continue Reading

Top 5 Most Recently Viewed Articles

Frigidaire Unveils Revolutionary Range for Perfect Pizzas

Updated Category News Views 114

Frigidaire Introduces an Innovative Pizza-Cooking Range Frigidaire has taken home cooking to the next level with its latest offering: the Frigidaire Gallery Range featuring the revolutionary Stone-Baked Pizza Mode. This innovative appliance safely reaches an impressive 750°F, allowing users to create authentic Neapolitan-style pizzas in just two minutes. This...

Continue Reading
Revelio Labs Unveils Employee-Linked Patents to Enhance Research

Updated Category News Views 426

Revelio Labs Launches Innovative Employee-Linked Patents Revelio Labs, recognized for its expertise in workforce intelligence, is addressing a significant deficiency in patent data research by introducing its cutting-edge Employee-Linked Patents product. This innovative solution links patents to the professional profiles of the inventors, enabling a comprehensive analysis...

Continue Reading
Maravai Lifesciences Faces Scrutiny: Investors Should Act

Updated Category News Views 127

Maravai Lifesciences Under Investigation Block & Leviton is currently investigating Maravai Lifesciences Holdings, Inc (NASDAQ: MRVI) for possible violations of securities laws. This inquiry comes as the company's stock has been experiencing significant fluctuations, drawing investors' attention. Recent Drop in Stock Price On the morning of February 25, 2025, shares of...

Continue Reading
UrbanDigs Launches Enhanced UD Advisor: Streamlined Service

Updated Category News Views 336

UrbanDigs Unveils Updated UD Advisor for Real Estate Agents The enhanced UD Advisor adds new features and speeds up delivery times for real estate professionals. This upgraded tool empowers agents with valuable market insights and custom reporting. Overview of the UD Advisor Service UrbanDigs, known for its real estate analytics, has made significant improvements to its...

Continue Reading
Celebrating Gugu Mkhize's Triumph at Prestigious Awards

Updated Category News Views 334

Gugu Mkhize Honored at the Global Brand Awards Ms. Gugu Mkhize has been recognized as the "Most Inspiring Women Leader (Insurance Training Authority) - 2023" during the prestigious Global Brand Awards. This award highlights remarkable achievements and leadership skills within the industry. What are the Global Brand Awards? The Global Brand Awards is a significant annual...

Continue Reading